Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sebastià Videla and A Antolí.
Sebastià Videla
Connection Strength
0.116
A Antolí
  1. Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? J Intern Med. 2021 06; 289(6):926-927.
    View in: PubMed
    Score: 0.058
  2. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemp Clin Trials Commun. 2021 Mar; 21:100716.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.